Initial public offering of Tryckinvest i Norden AB ("Tina") (SE) — SEK 1.2 billion TMT Initial public offering of Tryckinvest i Norden AB ("Tina") (SE) — SEK 1.2 billion
Directed issue of shares in Active Biotech (SE) — SEK 340 million Healthcare Directed issue of shares in Active Biotech (SE) — SEK 340 million
Divestment of NTS (SE) by Ratos (SE) to DanTransport (DK) — Amount not disclosed. Transportation & Shipping Divestment of NTS (SE) by Ratos (SE) to DanTransport (DK) — Amount not disclosed.
New share issue in SensoNor ASA (NO) — NOK 88 million TMT New share issue in SensoNor ASA (NO) — NOK 88 million
Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million Healthcare Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million
Initial public offering of CRI-Gruppen ASA (NO) — NOK 100 million TMT Initial public offering of CRI-Gruppen ASA (NO) — NOK 100 million
Directed share issue in MiniDoc AB (SE) — SEK 25 million Healthcare Directed share issue in MiniDoc AB (SE) — SEK 25 million
Acquisition of CarPark (SE) by UBS Capital B.V. (NL) — Amount not disclosed. Real Estate Acquisition of CarPark (SE) by UBS Capital B.V. (NL) — Amount not disclosed.
Rights issue in Active Biotech (SE) — SEK 255 million Healthcare Rights issue in Active Biotech (SE) — SEK 255 million
Secondary offering in Intentia (SE) — SEK 550 million TMT Secondary offering in Intentia (SE) — SEK 550 million
Initial public offering of Prevas (SE) — SEK 94 million TMT Initial public offering of Prevas (SE) — SEK 94 million
New share issue in Agresso ASA (NO) — NOK 120 million TMT New share issue in Agresso ASA (NO) — NOK 120 million